Variants in the genes encoding glucokinase regulator (GCKR) and membrane bound O-acyl transferase 7 (MBOAT7) also contribute to the risk of NAFLD, by increasing de novo lipogenesis and altering the remodeling of phospholipid. This evidence concerns the gene GCKR and metabolic dysfunction-associated steatotic liver disease.